Works matching DE "SIDE effects of antipsychotic drugs"
Results: 641
Tardive oculogyric crisis associated with amisulpride monotherapy.
- Published in:
- Journal of Postgraduate Medicine, 2010, v. 56, n. 4, p. 305, doi. 10.4103/0022-3859.70947
- By:
- Publication type:
- Article
Clinical update: Double-Blind Trial of Haloperidol, Chlorpromazine, and Lorazepam in the Treatment of Delirium in Hospitalized AIDS Patients. Breitbart, W., Marotta, R., Platt, M.M., Weisman, H., Derevenco, M., Grau, C., Corbera, K., Raymond, S., Lund, S. and Jacobsen, P. (1996) American Journal of Psychiatry 153 , 231–237.
- Published in:
- Psycho-Oncology, 1997, v. 6, n. 1, p. 75, doi. 10.1002/(SICI)1099-1611(199703)6:1<75::AID-PON259>3.0.CO;2-R
- By:
- Publication type:
- Article
Prescription persistence and safety of antipsychotic medication: a national registry-based 3-year follow-up.
- Published in:
- European Journal of Clinical Pharmacology, 2010, v. 66, n. 9, p. 911, doi. 10.1007/s00228-010-0839-9
- By:
- Publication type:
- Article
Olanzapine and pancytopenia with severe folate deficiency.
- Published in:
- 2010
- By:
- Publication type:
- Case Study
Effects of CYP2D6 polymorphisms on neuroleptic malignant syndrome.
- Published in:
- European Journal of Clinical Pharmacology, 2007, v. 63, n. 11, p. 991, doi. 10.1007/s00228-007-0355-8
- By:
- Publication type:
- Article
Ageing: Live faster, die younger.
- Published in:
- Nature, 2014, v. 508, n. 7494, p. S16, doi. 10.1038/508S16a
- By:
- Publication type:
- Article
Pharmacological management of antipsychotic-induced akathisia: an update and treatment algorithm.
- Published in:
- BJPsych Advances, 2015, v. 21, n. 5, p. 342, doi. 10.1192/apt.bp.114.013797
- By:
- Publication type:
- Article
Hyperprolactinaemia and antipsychotics.
- Published in:
- BJPsych Advances, 2015, v. 21, n. 4, p. 240, doi. 10.1192/apt.bp.113.012088
- By:
- Publication type:
- Article
Early schizophrenia: skilful management of medication.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
Long-term effects of antipsychotics.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
Olanzapine Sensitization and Clozapine Tolerance: From Adolescence to Adulthood in the Conditioned Avoidance Response Model.
- Published in:
- Neuropsychopharmacology, 2013, v. 38, n. 3, p. 513, doi. 10.1038/npp.2012.213
- By:
- Publication type:
- Article
Incidence of Tardive Dyskinesia with Risperidone or Olanzapine in the Elderly: Results from a 2-Year, Prospective Study in Antipsychotic-Naïve Patients.
- Published in:
- Neuropsychopharmacology, 2011, v. 36, n. 8, p. 1738, doi. 10.1038/npp.2011.55
- By:
- Publication type:
- Article
HI-Histamine Receptor Affinity Predicts Short-Term Weight Gain for Typical and Atypical Antipsychotic Drugs.
- Published in:
- Neuropsychopharmacology, 2003, v. 28, n. 3, p. 519, doi. 10.1038/sj.npp.1300027
- By:
- Publication type:
- Article
Electroconvulsive therapy in schizophrenia – where do we stand?
- Published in:
- European Psychiatry, 2016, v. 33, p. S310, doi. 10.1016/j.eurpsy.2016.01.671
- By:
- Publication type:
- Article
Antipsychotic-induced tardive dyskinesia: The role of glutamatergic system.
- Published in:
- European Psychiatry, 2016, v. 33, p. S98, doi. 10.1016/j.eurpsy.2016.01.069
- By:
- Publication type:
- Article
Paliperidone palmitate in psychogeriatric patients and new criteria STOPP-START.
- Published in:
- European Psychiatry, 2016, v. 33, p. S584, doi. 10.1016/j.eurpsy.2016.01.1719
- By:
- Publication type:
- Article
Cost-utility Analysis of Lurasidone Versus Aripiprazole in Adults with Schizophrenia in Scotland.
- Published in:
- European Psychiatry, 2015, v. 30, p. 1605, doi. 10.1016/S0924-9338(15)31239-6
- By:
- Publication type:
- Article
The interaction of subjective experience and attitudes towards specific antipsychotic-related adverse effects in schizophrenia patients.
- Published in:
- European Psychiatry, 2013, v. 28, n. 6, p. 340, doi. 10.1016/j.eurpsy.2012.06.005
- By:
- Publication type:
- Article
P-1292 - The effect of nicotine on cognitive and psychomotor functioning in smoking and non smoking patients with schizophrenia and young and old healthy volunteers
- Published in:
- 2012
- By:
- Publication type:
- Abstract
P-1232 - Hyperthermic catatonia and electroconvulsive therapy: analysis of a successful case
- Published in:
- 2012
- By:
- Publication type:
- Abstract
P-1231 - Antipsychotics and erectile dysfunction: study in a population of moroccan schizophrenic
- Published in:
- 2012
- By:
- Publication type:
- Abstract
P-1196 - Pulmonary thromboembolism induced by clozapine and high doses of first-generation antipsychotics
- Published in:
- 2012
- By:
- Publication type:
- Abstract
P-1124 - Neuroleptic Malignant Syndrome during amisulpride therapy - a case presentation
- Published in:
- 2012
- By:
- Publication type:
- Abstract
P-1107 - Anticholinergic side effects of antipsychotic medications
- Published in:
- 2012
- By:
- Publication type:
- Abstract
P-1104 - The effect of clozapine on the expression of obesity genes
- Published in:
- 2012
- By:
- Publication type:
- Abstract
P03-126 - Cardiovascular side effects, QT interval in patients treated with some selected antypsychotics. preliminary results
- Published in:
- 2011
- By:
- Publication type:
- Abstract
P03-197 - Daytime sleepiness, executive functions and working memory in schizophrenia patients treated with sertindole and olanzapine
- Published in:
- 2011
- By:
- Publication type:
- Abstract
P03-105 - Screening of metabolic side effects of antipsychotics in patients with mental disorder
- Published in:
- 2011
- By:
- Publication type:
- Abstract
P03-291 - Physical care of people suffering from schizopphrenia on risperidone long acting injectable depot
- Published in:
- 2011
- By:
- Publication type:
- Abstract
P03-51 - Obsessive-compulsive symptoms induced by atypical anti-psychotics
- Published in:
- 2011
- By:
- Publication type:
- Abstract
P03-86 - Metabolic syndrome in schizophrenia -impact of antipsychotic medication
- Published in:
- 2011
- By:
- Publication type:
- Abstract
S39-04 - Physical health in schizophrenia - what's cognition got to do with it?
- Published in:
- 2011
- By:
- Publication type:
- Abstract
P02-496 - Fluphenazine in the pregnancy
- Published in:
- 2011
- By:
- Publication type:
- Abstract
S24-01 - High-risk-states for psychoses and schizophrenia
- Published in:
- 2011
- By:
- Publication type:
- Abstract
FC13-10 - Frequency of prolonged qtc in children and adolescents hospitalized for psychiatric disorders: a nested case-control study
- Published in:
- 2011
- By:
- Publication type:
- Abstract
P03-66 - Neuroleptic malignant syndrome
- Published in:
- 2011
- By:
- Publication type:
- Abstract
P03-352 - Low rates of treatment of cardiovascular risk factors in patients treated with antipsychotics
- Published in:
- 2011
- By:
- Publication type:
- Abstract
P02-355 - Tardive dyskinesia induced by quetiapine and confirmed by a Dat-scan
- Published in:
- 2011
- By:
- Publication type:
- Abstract
PW01-207 - Quality of care and crime rates among patients with schizophrenia: a nationwide population-based follow-up study
- Published in:
- 2010
- By:
- Publication type:
- Abstract
PW01-186 - Effects of longterm treatment with atypical neuroleptics for patients with schizophrenia (ELAN): medication use, adherence, functional impairment, quality of life
- Published in:
- 2010
- By:
- Publication type:
- Abstract
P01-31 - Use of aripiprazole and paroxetine in the treatment of patient with bipolar depression (bipolar disorder II, BDII) case report
- Published in:
- 2010
- By:
- Publication type:
- Abstract
S28-01 - Pharmacogenetics of the metabolic consequences of antipsychotic drug treatment
- Published in:
- 2010
- By:
- Publication type:
- Abstract
How can antipsychotics cause diabetes mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins
- Published in:
- European Psychiatry, 2009, v. 24, n. 3, p. 164, doi. 10.1016/j.eurpsy.2009.01.001
- By:
- Publication type:
- Article
P03-109 The malignant neuroleptic syndrome: Etiopathogenesis, diagnosis and clinics
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Prevalence of neuroleptic malignant syndrome in 672 consecutive male in-patients.
- Published in:
- Indian Journal of Psychiatry, 2009, v. 51, n. 3, p. 202, doi. 10.4103/0019-5545.55089
- By:
- Publication type:
- Article
A case of neuroleptic malignant syndrome induced by olanzapine in postpartum period.
- Published in:
- Indian Journal of Psychiatry, 2007, v. 49, n. 4, p. 287, doi. 10.4103/0019-5545.37671
- By:
- Publication type:
- Article
Safer alternatives to long-term use of antipsychotic drugs sought.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Hyperprolactinemia and amenorrhea associated with olanzapine normalized after addition of aripiprazole.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2007, v. 32, n. 2, p. 197, doi. 10.1111/j.1365-2710.2007.00806.x
- By:
- Publication type:
- Article
Clinically significant pharmacokinetic drug interactions with psychoactive drugs: antidepressants and antipsychotics and the cytochrome P450 system.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 1999, v. 24, n. 1, p. 7, doi. 10.1046/j.1365-2710.1999.00200.x
- By:
- Publication type:
- Article
Glucagon‐like peptide‐1 receptor agonists for antipsychotic‐associated cardio‐metabolic risk factors: A systematic review and individual participant data meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 293, doi. 10.1111/dom.13522
- By:
- Publication type:
- Article